G49108TO
| Organisms | Evidence |
|---|---|
| Mus musculus (house mouse) | |
| Rattus norvegicus (Norway rat) | |
| Homo sapiens (human) | |
| Drosophila melanogaster (fruit fly) | |
| Streptococcus pneumoniae |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B4GALT1 | UDP-Gal |
|
R |
|
R | |
| B3GALT5 | UDP-Gal |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT3 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-Benzl |
|
[beta]-1-Benzl | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl |
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Xenopus tropicalis |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Danio rerio |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Homo sapiens |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 38889725 | H19 influenza A virus exhibits species-specific MHC class II receptor usage | Karakus U | 2024 Jul 10 |
|
| 38942028 | O-GlcNAcase regulates pluripotency states of human embryonic stem cells | Liu Q | 2024 Jul 09 |
|
| 38980922 | An antibody that inhibits TGF-β1 release from latent extracellular matrix complexes attenuates the progression of renal fibrosis | Jackson JW | 2024 Jul 09 |
|
| 38977690 | SPRING licenses S1P-mediated cleavage of SREBP2 by displacing an inhibitory pro-domain | Hendrix S | 2024 Jul 09 |
|
| 38973679 | Heparosan biosynthesis in recombinant Bacillus megaterium: Influence of N‐acetylglucosamine supplementation and kinetic modeling | Nehru G | 2024 Jul 08 |
|
| 38959313 | The structure of immature tick-borne encephalitis virus supports the collapse model of flavivirus maturation | Anastasina M | 2024 Jul 05 |
|
| 38788561 | Synthesis, cytotoxicity and antioxidant activity of new conjugates of N-acetyl-d-glucosamine with α-aminophosphonates | Khabibulina LR | 2024 Jul |
|
| 39218718 | [Deficiency in N-acetylglucosamine transport affects the sporulation process and increases the hemolytic activity of the S-layer protein in Lysinibacillus sphaericus ASB13052] | Tarsitano J | 2024 Jul |
|
| 38214432 | Androgen-repressed lncRNA LINC01126 drives castration-resistant prostate cancer by regulating the switch between O-GlcNAcylation and phosphorylation of androgen receptor | Cai Y | 2024 Jan |
|
| 38289573 | O-GlcNAcylation of CSNK2A1 by OGT is Involved in the Progression of Colorectal Cancer | Yu Z | 2024 Jan 30 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025